杨瑾

摘要：目的：對比观察蒙脱石散与双歧杆菌乳杆菌三联活菌片联合治疗腹泻患儿的应用价值。方法：选取我院从2020年3月至2021年3月收治的腹泻患儿108例作为观察对象进行回顾性分析，将符合标准条件的腹泻患儿使用随机数字表法均等分为对照组和观察组两组进行对比，每组各54例，两组患儿均行常规对症治疗，补液纠正电解质紊乱，营养支持补充维生素，抗感染治疗，对照组患儿在常规对症治疗的基础上使用蒙脱石散进行治疗，观察组患儿在同上常规对症治疗以及蒙脱石散治疗的基础上增加使用双歧杆菌乳杆菌三联活菌片进行治疗。结果：使用双歧杆菌乳杆菌三联活菌片和蒙脱石散联合治疗的腹泻患儿（观察组）粪便成形、大便次数、呕吐停止、体温复常等均优于单独使用蒙脱石散的患儿（对照组）（P<0.05）。使用双歧杆菌乳杆菌三联活菌片和蒙脱石散联合治疗的腹泻患儿（观察组）治疗效果明显优于单独使用蒙脱石散的患儿（对照组）（P<0.05）。使用双歧杆菌乳杆菌三联活菌片和蒙脱石散联合治疗的腹泻患儿（观察组）治疗后阳性率明显低于单独使用蒙脱石散的患儿（对照组）（P<0.05）。结论：对腹泻患儿联合使用双歧杆菌乳杆菌三联活菌片和蒙脱石散进行治疗效果正面积极且明显。

关键词：双歧杆菌乳杆菌三联活菌片;蒙脱石散;联合治疗;小儿腹泻;临床观察

[Abstract]Objective：To compare and observe the application value of montmorillonite powder and Bifidobacterium Lactobacillus triple viable tablets in the treatment of children with diarrhea.Methods：108 children with diarrhea admitted to our hospital from March 2020 to March 2021 were selected as observation objects for retrospective analysis，and the children with diarrhea meeting the standard conditions were equally divided into the control group and the observation group using a random number table method The two groups were compared，54 cases in each group.Children in both groups received conventional symptomatic treatment，fluid replacement to correct electrolyte disturbances，nutritional support and vitamin supplementation，and anti-infection treatment.Children in the control group were treated with montmorillonite on the basis of conventional symptomatic treatment.Stone powder was used for treatment，and the observation group was treated with Bifidobacterium Lactobacillus triple live bacteria tablets on the basis of the same conventional symptomatic treatment and montmorillonite powder treatment.Results：The children with diarrhea treated with Bifidobacterium Lactobacillus triple viable tablets and montmorillonite powder （observation group） were better than those treated with montmorillonite powder alone （control group） （P < 0.05） The positive rate of diarrhea children treated with Bifidobacterium Lactobacillus triple viable tablets and montmorillonite powder （observation group） was significantly lower than that of children treated with montmorillonite powder （control group） （P < 0.05）.Conclusion：The combined use of Bifidobacterium Lactobacillus triple viable tablets and montmorillonite powder for children with diarrhea has a positive and obvious therapeutic effect.

[Keywords]Bifidobacterium Lactobacillus triple live bacteria tablets;Montmorillonite powder;Combination therapy;Pediatric diarrhea;Clinical observation

【中图分类号】R4 【文献标识码】A 【文章编号】2107-2306（2021）14-01

小儿腹泻是临床中十分常见于幼童的一种儿科疾病，多重病毒、病菌感染所致，其中轮状病毒为常见主要病原体之一，它的病理机制是由于病毒感染作用于上皮细胞，使其细胞结构损伤而引起腹泻。……